@xconomy.com 4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@slashgear.com 4 years ago
Fake coronavirus cures targeted by feds as infections rise
@xconomy.com 4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com 4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com 5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com 5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@theverge.com 8 years ago
FDA panel recommends approving new drug that dramatically lowers cholesterol
@venturebeat.com 9 years ago
Apple ResearchKit could open up a whole new era of clinical trials